Tension-Time Integrals and Genetic Cardiomyopathy: The Force Is with You

Gerald W Dorn1

  • 1Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell
|May 21, 2016
PubMed

Insights

Sarcomeric protein mutations cause hypertrophic or dilated cardiomyopathy. A new metric, the force-time integral, predicts which cardiac remodeling pattern will develop, clarifying disease mechanisms.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biophysics

Background:

  • Genetic mutations in sarcomeric proteins lead to hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM).
  • The precise mechanisms by which these molecular defects result in distinct cardiac remodeling patterns remain poorly understood.

Purpose of the Study:

  • To identify a biophysical metric that can predict the specific disease phenotype (HCM or DCM) arising from sarcomeric protein mutations.
  • To elucidate the relationship between cardiomyocyte function and cardiac remodeling patterns.

Main Methods:

  • Analysis of cardiomyocyte function using a novel biophysical metric.
  • Correlation of the metric with observed disease phenotypes in human cardiac conditions.

Main Results:

  • The force-time integral, a measure of cardiomyocyte contractile function, was identified as a key predictor of disease phenotype.
  • This metric effectively distinguishes between the molecular underpinnings of hypertrophic versus dilated cardiomyopathy.

Conclusions:

  • The force-time integral offers a valuable tool for predicting cardiomyopathy type based on cardiomyocyte dysfunction.
  • Understanding this biophysical metric advances knowledge of cardiac remodeling and disease pathogenesis in inherited cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
728
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
775
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
751